Human CD29+/CD56+ myogenic progenitors display tenogenic differentiation potential and facilitate tendon regeneration

Tendon injury occurs at high frequency and is difficult to repair. Identification of human stem cells being able to regenerate tendon will greatly facilitate the development of regenerative medicine for tendon injury. Genetic and functional analyses identify human CD29+/CD56+ myogenic progenitors with tenogenic differentiation potential in vitro and in vivo. Transplantation of human CD29+/CD56+ myogenic progenitors contributes to injured tendon repair and thus improves locomotor function. Interestingly, the tendon differentiation potential in mouse muscle stem cells is minimal and the higher TGFβ signaling level may be the key for the distinct feature of human CD29+/CD56+ myogenic progenitors. The discovery of bi-potential CD29+/CD56+ myogenic progenitors highlights their potential as a novel adult stem cell source for tendon regeneration.

Authors

Institutions

Publication Details

Journal
eLife
Published
2025-05-19
DOI
https://doi.org/10.7554/elife.98636.3
Citations
1
Primary Topic
Tendon Structure and Treatment
Type
article
Field-Weighted Citation Impact
1.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human CD29+/CD56+ myogenic progenitors display tenogenic differentiation potential and facilitate tendon regeneration

Lili Han, Minghui Wang, Zhanghua Li, Xingzuan Lin et al.
1 citations
eLife
Tendon Structure and Treatment
1.72
article

Human CD29+/CD56+ myogenic progenitors display tenogenic differentiation potential and facilitate tendon regeneration

Lili Han, Minghui Wang, Zhanghua Li, Xingzuan Lin, Shenao Zhou, Xiexiang Shao, Siyuan Zhu, Sheng Li, Jianhua Wang, Wenjun Yang, Xin Fu, Hao Zhou, Ping Hu
article en
1 citations

Abstract

Tendon injury occurs at high frequency and is difficult to repair. Identification of human stem cells being able to regenerate tendon will greatly facilitate the development of regenerative medicine for tendon injury. Genetic and functional analyses identify human CD29+/CD56+ myogenic progenitors with tenogenic differentiation potential in vitro and in vivo. Transplantation of human CD29+/CD56+ myogenic progenitors contributes to injured tendon repair and thus improves locomotor function. Interestingly, the tendon differentiation potential in mouse muscle stem cells is minimal and the higher TGFβ signaling level may be the key for the distinct feature of human CD29+/CD56+ myogenic progenitors. The discovery of bi-potential CD29+/CD56+ myogenic progenitors highlights their potential as a novel adult stem cell source for tendon regeneration.

eLifeVol. 13
Fujian Medical University (CN), Shanghai Jiao Tong University (CN), Chinese Academy of Sciences (CN), Peking University (CN), XinHua Hospital (CN), Institute for Stem Cell Biology and Regenerative Medicine (IN), Tongren Hospital (CN), Center for Excellence in Molecular Cell Science (CN), Wuhan Third Hospital (CN), Peking University Third Hospital (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 19%
Tendon Structure and Treatment
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.